Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3269493 | HPB | 2010 | 14 Pages |
Abstract
Malignant transformation of HCAs into HCCs remains a rare phenomenon with a reported frequency of 4.2%. A better selection of exactly those patients presenting with an HCA with an amplified risk of malignant degeneration is advocated in order to reduce the number of liver resections and thus reducing the operative risk for these predominantly young patients. The Bordeaux adenoma tumour markers are a promising method of identifying these high-risk adenomas.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Jan H.M.B. Stoot, Robert J.S. Coelen, Mechteld C. De Jong, Cornelis H.C. Dejong,